Published in Immunology on September 01, 1977
Cell selection by antigen in the immune response. Adv Immunol (1969) 6.05
Properties of primed suppressor T cells and their products. Transplant Rev (1975) 3.42
T cell-dependent suppression of an anti-hapten antibody response. Transplant Rev (1975) 3.06
Radioresistance of the enhancing effect of cells from carrier-immunized mice in an in vitro primary immune response. Proc Natl Acad Sci U S A (1971) 2.79
RADIOSENSITIVITY OF THE IMMUNE RESPONSE TO SHEEP RED CELLS IN THE MOUSE, AS MEASURED BY THE HEMOLYTIC PLAQUE METHOD. J Immunol (1965) 2.68
Induction of specific suppressor T cells in vitro. J Immunol (1976) 2.44
Radioresistance of carrier-specific helper thymus-derived lymphocytes in mice. Proc Natl Acad Sci U S A (1972) 2.35
Distribution of antibody affinities: technique of measurement. Immunochemistry (1972) 2.24
Effect of thymus-derived lymphocytes on amount and affinity of anti-hapten antibody. J Immunol (1971) 2.19
In vivo requirement for a radiation-resistant cells in the immune response to sheep erythrocytes. J Exp Med (1971) 1.41
Radiosensitivity of T and B lymphocytes. I. Effect of irradiation on cell migration. Eur J Immunol (1974) 1.31
Influence of irradiation on resistance to infection. Bacteriol Rev (1960) 1.19
The radiosensitivity of T and B lymphocytes in mice. Immunology (1975) 1.18
Thymus dependence of adoptive immunity in irradiated mice. Transplantation (1968) 0.94
The effect of in vivo irradiation on macrophage function. J Immunol (1973) 0.87
Further studies on the radioresistance of antibody producing cells: characterization of the survival curve. Radiat Res (1971) 0.83
Enhanced antibody affinity in sublethally irradiated mice and bone marrow chimeras. Proc Natl Acad Sci U S A (1977) 0.82
Immune responsiveness and incidence of reticulum cell sarcoma in long-term syngeneic radiation chimeras. Transplantation (1976) 0.78
The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses. Annu Rev Immunol (1998) 5.50
Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures. J Exp Med (1997) 4.04
1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol (2000) 3.82
Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. J Immunol (2001) 2.75
Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice. J Exp Med (1995) 2.29
Why peptides? Their possible role in the evolution of MHC-restricted T-cell recognition. Immunol Today (1989) 2.23
Fine specificity of regulatory T cells. II. Suppressor and helper T cells are induced by different regions of hen egg-white lysozyme in a genetically nonresponder mouse strain. J Exp Med (1979) 2.12
Predominant contribution of IgA antibody-forming cells to an immune response detected in extraintestinal lymphoid tissues of germ-free mice exposed to antigen by the oral route. J Immunol (1970) 2.06
Mechanisms influencing the immunodominance of T cell determinants. J Exp Med (1988) 1.91
Different functional specificity repertoires for suppressor and helper T cells. Immunol Rev (1978) 1.91
Regulation of the macrophage content of neoplasms by chemoattractants. Science (1983) 1.83
Natural and antibody-dependent cell-mediated activity against Salmonella typhimurium by peripheral and intestinal lymphoid cells in mice. J Immunol (1983) 1.82
Cutting edge: selective usage of chemokine receptors by plasmacytoid dendritic cells. J Immunol (2001) 1.82
Cardiomyocytes induce endothelial cells to trans-differentiate into cardiac muscle: implications for myocardium regeneration. Proc Natl Acad Sci U S A (2001) 1.81
Environmental tobacco smoke exposure in public places of European cities. Tob Control (2005) 1.80
Regulation of T-cell responses by CNS antigen-presenting cells: different roles for microglia and astrocytes. Immunol Today (2000) 1.77
Interleukin 1-induced augmentation of experimental metastases from a human melanoma in nude mice. Cancer Res (1990) 1.77
Interferon-gamma reduces macrophage-suppressive activity by inhibiting prostaglandin E2 release and inducing interleukin 1 production. J Immunol (1984) 1.75
Natural killer activity of gut mucosal lymphoid cells in mice. Eur J Immunol (1981) 1.73
Morphological characterization of a cell population responsible for natural killer activity. Immunology (1981) 1.73
Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients. J Clin Invest (1993) 1.73
Antibody-dependent cell-mediated antibacterial activity of intestinal lymphocytes with secretory IgA. Nature (1984) 1.71
Leukocyte recruitment in the cerebrospinal fluid of mice with experimental meningitis is inhibited by an antibody to junctional adhesion molecule (JAM). J Exp Med (1999) 1.68
The role of Stat4 in species-specific regulation of Th cell development by type I IFNs. J Immunol (1998) 1.65
Capacity of intact proteins to bind to MHC class II molecules. J Immunol (1989) 1.63
Selective development of T helper (Th)2 cells induced by continuous administration of low dose soluble proteins to normal and beta(2)-microglobulin-deficient BALB/c mice. J Exp Med (1996) 1.61
Dendritic cells but not B cells present antigenic complexes to class II-restricted T cells after administration of protein in adjuvant. J Exp Med (1996) 1.58
The control of T cell responses by dendritic cell subsets. Curr Opin Immunol (2000) 1.53
The role of IL-12 in the induction of organ-specific autoimmune diseases. Immunol Today (1995) 1.51
Interaction of an immunodominant epitope with Ia molecules in T-cell activation. Proc Natl Acad Sci U S A (1988) 1.51
Defective tumoricidal capacity of macrophages from A/J mice. II. Comparison of the macrophage cytotoxic defect of A/J mice with that of lipid A-unresponsive C3H/HeJ mice. J Immunol (1979) 1.48
Chronic inflammation in the pathogenesis of benign prostatic hyperplasia. Int J Androl (2009) 1.43
The fine specificity of regulatory T cells. IV. Idiotypic complementarity and antigen-bridging interactions in the anti-lysozyme response. Eur J Immunol (1979) 1.42
Caspase-1 regulates the inflammatory process leading to autoimmune demyelination. J Immunol (1999) 1.42
Lysozyme-induced T-suppressor cells and antibodies have a predominant idiotype. Nature (1979) 1.40
Enhancing activity of thymocyte culture cell-free medium on the in vitro immune response of spleen cells from neonatally thymectomized mice to sheep RBC. J Immunol (1972) 1.34
Functional maturation of adult mouse resting microglia into an APC is promoted by granulocyte-macrophage colony-stimulating factor and interaction with Th1 cells. J Immunol (2000) 1.33
IL-12 production by central nervous system microglia is inhibited by astrocytes. J Immunol (1997) 1.31
Macrophage activation for tumor cytotoxicity: analysis of intermediary reactions. J Reticuloendothel Soc (1979) 1.31
IL-12: a key cytokine in immune regulation. Immunol Today (1996) 1.31
A short synthetic peptide fragment of human interleukin 1 with immunostimulatory but not inflammatory activity. J Immunol (1986) 1.30
IgA-driven T cell-mediated anti-bacterial immunity in man after live oral Ty 21a vaccine. J Immunol (1986) 1.30
Intrathecal delivery of IFN-gamma protects C57BL/6 mice from chronic-progressive experimental autoimmune encephalomyelitis by increasing apoptosis of central nervous system-infiltrating lymphocytes. J Immunol (2001) 1.29
Inhibition of Th1 development and treatment of chronic-relapsing experimental allergic encephalomyelitis by a non-hypercalcemic analogue of 1,25-dihydroxyvitamin D(3). Eur J Immunol (2000) 1.28
Competition for antigen presentation in living cells involves exchange of peptides bound by class II MHC molecules. Nature (1989) 1.26
IgA-dependent cell-mediated activity against enteropathogenic bacteria: distribution, specificity, and characterization of the effector cells. J Immunol (1984) 1.24
The type II IL-1 receptor interacts with the IL-1 receptor accessory protein: a novel mechanism of regulation of IL-1 responsiveness. J Immunol (1998) 1.24
Efficient immune responses in mice lacking N-region diversity. Eur J Immunol (1995) 1.22
Microglia are more efficient than astrocytes in antigen processing and in Th1 but not Th2 cell activation. J Immunol (1998) 1.22
Dendritic cells are the most efficient in presenting endogenous naturally processed self-epitopes to class II-restricted T cells. J Immunol (1995) 1.19
Determinant capture as a possible mechanism of protection afforded by major histocompatibility complex class II molecules in autoimmune disease. J Exp Med (1993) 1.19
Elocalcitol inhibits inflammatory responses in human thyroid cells and T cells. Endocrinology (2008) 1.18
Regulation of arachidonic acid metabolism in macrophages by immune and nonimmune interferons. J Immunol (1985) 1.17
In vivo immunostimulating activity of the 163-171 peptide of human IL-1 beta. J Immunol (1987) 1.16
Natural anti-bacterial activity against Salmonella typhi by human T4+ lymphocytes armed with IgA antibodies. J Immunol (1985) 1.16
Cellular immunity against Salmonella typhi after live oral vaccine. Clin Exp Immunol (1985) 1.15
Pancreas-infiltrating Th1 cells and diabetes develop in IL-12-deficient nonobese diabetic mice. J Immunol (1999) 1.14
Age-dependent variations of antibody avidity. Immunology (1978) 1.13
Acceleration of intracellular targeting of antigen by the B-cell antigen receptor: importance depends on the nature of the antigen-antibody interaction. EMBO J (1997) 1.12
Macrophage activation for tumor cytotoxicity: genetic variation in macrophage tumoricidal capacity among mouse strains. Cell Immunol (1979) 1.11
Use of hematopoietic cytokines to accelerate the recovery of the immune system in irradiated mice. Exp Hematol (1997) 1.10
In vitro primary immune response resulting from the interaction between bone marrow-derived and thymus cells. Experientia (1970) 1.10
Deviation of pancreas-infiltrating cells to Th2 by interleukin-12 antagonist administration inhibits autoimmune diabetes. Eur J Immunol (1997) 1.10
IL-11 synergizes with IL-3 in promoting the recovery of the immune system after irradiation. Int Immunol (1996) 1.10
Structural requirements for the interaction between peptide antigens and I-Ed molecules. J Immunol (1989) 1.09
A peptide-binding motif for I-A(g7), the class II major histocompatibility complex (MHC) molecule of NOD and Biozzi AB/H mice. J Exp Med (1997) 1.09
IL-10 is required for development of protective Th1 responses in IL-12-deficient mice upon Candida albicans infection. J Immunol (1998) 1.09
Effects of in vivo treatments with cyclosporin-A on mouse cell-mediated immune responses. Int J Immunopharmacol (1981) 1.08
Selective vitamin D receptor modulators and their effects on colorectal tumor growth. J Steroid Biochem Mol Biol (2007) 1.08
Defective tumoricidal capacity of macrophages from A/J mice. I. Characterization of the macrophage cytotoxic defect after in vivo and in vitro activation stimuli. J Immunol (1979) 1.07
Melatonin increases antigen presentation and amplifies specific and non specific signals for T-cell proliferation. Int J Immunopharmacol (1993) 1.06
Differential binding of IL-1 alpha and IL-1 beta to receptors on B and T cells. FEBS Lett (1989) 1.05
Model of interaction of the IL-1 receptor accessory protein IL-1RAcP with the IL-1beta/IL-1R(I) complex. FEBS Lett (2001) 1.05
In vitro generated mast cells express natural cytotoxicity against tumour cells. Immunology (1985) 1.05
Processing of an endogenous protein can generate MHC class II-restricted T cell determinants distinct from those derived from exogenous antigen. J Immunol (1991) 1.04
IFN-beta-induced reduction of superoxide anion generation by macrophages. Immunology (1982) 1.04
The fine specificity of regulatory T cells. I. Hen egg-white lysozyme-induced suppressor T cells in a genetically nonresponder mouse strain do not recognize a closely related immunogenic lysozyme. J Immunol (1979) 1.04
Interferon-induced enhancement of macrophage-mediated tumor cytolysis and its difference from activation by lymphokines. Eur J Immunol (1981) 1.04
Inheritance of immune responsiveness, life span, and disease incidence in interline crosses of mice selected for high or low multispecific antibody production. J Immunol (1989) 1.03
Role of metalloproteases in the release of the IL-1 type II decoy receptor. J Biol Chem (1997) 1.02
The effect of thymic action on the precursors of antigen-sensitive cells. Proc Natl Acad Sci U S A (1967) 1.02
Defective tumoricidal capacity of macrophages from A/J mice. III. Genetic analysis of the macrophage defect. J Immunol (1980) 1.02
Interferon inhibits prostaglandin biosynthesis in macrophages: effects on arachidonic acid metabolism. J Immunol (1984) 1.02
Antigen presentation of hen egg-white lysozyme but not of ribonuclease A is augmented by the major histocompatibility complex class II-associated invariant chain. Eur J Immunol (1991) 1.02
Defective tumoricidal capacity of macrophages from P/J mice: tumoricidal defect involves abnormalities in lymphokine-derived activation stimuli and in mononuclear phagocyte responsiveness. J Immunol (1980) 1.02
Correlation between the lipopolysaccharide response of mice and the capacity of mouse peritoneal cells to transfer an antiviral state. Role of endogenous interferon. J Immunol (1987) 1.01
Immunoreactivity for IL-1 beta and TNF alpha in human lymphoid and nonlymphoid tissues. Am J Pathol (1989) 1.01
Enhancement of in vivo immune response by tumor necrosis factor. J Immunol (1987) 1.00
The human bone-marrow-derived B-cell line CE, susceptible to hepatitis C virus infection. Res Virol (1993) 1.00
A microcomputer program for probit analysis of interleukin-2 (IL-2) titration data. J Immunol Methods (1986) 1.00
Effects of antithyroid therapy on the long-acting thyroid stimulator and the antithyroglobulin antibodies. J Clin Endocrinol Metab (1969) 1.00
The frequency of high avidity T cells determines the hierarchy of determinant spreading. J Immunol (2001) 1.00
CD40-CD154 interaction and IFN-gamma are required for IL-12 but not prostaglandin E2 secretion by microglia during antigen presentation to Th1 cells. J Immunol (1999) 1.00
Chemotactic activity for mononuclear phagocytes of culture supernatants from murine and human tumor cells: evidence for a role in the regulation of the macrophage content of neoplastic tissues. Int J Cancer (1983) 0.99
Failure to demonstrate long-lived MHC saturation both in vitro and in vivo. Implications for therapeutic potential of MHC-blocking peptides. J Immunol (1994) 0.99
In vivo restoration of T cell functions by human IL-1 beta or its 163-171 nonapeptide in immunodepressed mice. J Immunol (1988) 0.98